• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

240-Degree Goniotomy Shows Promise for Primary Congenital Glaucoma in Small Case Series

by
October 28, 2026
in Health
Reading Time: 2 mins read
0
240-Degree Goniotomy Shows Promise for Primary Congenital Glaucoma in Small Case Series

240-Degree Goniotomy Shows Promise for Primary Congenital Glaucoma in Small Case Series

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The study reviewed consecutive patients with primary congenital glaucoma who underwent the procedure and had at least six months of follow-up. In total, 12 eyes of 9 patients were included. The median age at surgery was 5.8 years, with an interquartile range of 5.3 to 6.8 years and a full range spanning 2.5 to 31.0 years. Eight of the 12 eyes, or 66.7 percent, belonged to male patients.

After a mean follow-up of 15.4 plus or minus 11.9 months, ranging from 6 to 49 months, intraocular pressure fell from 31.7 plus or minus 6.6 mmHg before surgery to 16.4 plus or minus 4.5 mmHg at the final visit, a reduction of 46.4 percent that was statistically significant. The number of antiglaucoma medications dropped from 2.9 plus or minus 0.9 to 1.4 plus or minus 1.5 over the same period.

The researchers defined complete success as an intraocular pressure of 21 mmHg or lower without medications or additional glaucoma surgery, and qualified success as an intraocular pressure of 21 mmHg or lower with or without medications and no reoperation. By these criteria, the complete success rate was 41.7 percent and the qualified success rate was 91.7 percent at final follow-up.

Safety was a central focus of the analysis. The authors report that there were no vision-threatening intraoperative or postoperative complications in the series, which included eyes with prior failed glaucoma surgery.

Notably, the series included eyes with prior failed glaucoma surgery, a group that is often difficult to manage. The authors conclude that the findings suggest 240-degree goniotomy is promising both for primary congenital glaucoma generally and for patients who have already undergone other glaucoma procedures.

The study’s authors caution, through the design itself, that these results come from a small retrospective case series of 12 eyes with variable follow-up, so the success and complication rates should be interpreted as preliminary observations rather than definitive estimates of efficacy.

Subject of Research: Outcomes of 240-degree goniotomy surgery in primary congenital glaucoma

Article Title: Outcomes of 240-degree goniotomy in primary congenital glaucoma: a retrospective case series

Article References: Xie, B., Yang, Z., Wang, Z., Fang, Z., Song, Y., Lin, F., & Zhang, X. (2026). Outcomes of 240-degree goniotomy in primary congenital glaucoma: a retrospective case series. BMC Ophthalmology. https://doi.org/10.1186/s12886-026-05446-9

Image Credits: AI Generated

DOI: 10.1186/s12886-026-05446-9

Keywords: primary congenital glaucoma, goniotomy, intraocular pressure, glaucoma surgery, trabecular meshwork, case series, ophthalmology, BMC Ophthalmology, surgical outcomes, antiglaucoma medications, Outcomes, degree

News Source: Ophelia Keating. (October 28, 2026). 240-Degree Goniotomy Shows Promise for Primary Congenital Glaucoma in Small Case Series. Scienmag.

Tags: antiglaucoma medicationsBMC Ophthalmologycase seriesdegreeglaucoma surgerygoniotomyintraocular pressureOphthalmologyoutcomesprimary congenital glaucomasurgical outcomestrabecular meshwork
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.